Variations of SARS-CoV-2 in the Iranian population and candidate putative drug-like compounds to inhibit the mutated proteins

The first cases of the novel coronavirus, SARS-CoV-2, were detected in December 2019 in Wuhan, China. Nucleotide substitutions and mutations in the SARS-CoV-2 sequence can result in the evolution of the virus and its rapid spread across the world. Therefore, understanding genetic variants of SARS-Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Mortezaei, Zahra, Mohammadian, Ali, Tavallaei, Mahmood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271419/
https://www.ncbi.nlm.nih.gov/pubmed/35847618
http://dx.doi.org/10.1016/j.heliyon.2022.e09910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271419/
https://www.ncbi.nlm.nih.gov/pubmed/35847618
http://dx.doi.org/10.1016/j.heliyon.2022.e09910

Ejemplares similares